BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1166 related articles for article (PubMed ID: 30695734)

  • 1. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
    Sankrityayan H; Kulkarni YA; Gaikwad AB
    Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between the miRNome and the epigenetic machinery: Implications in health and disease.
    Poddar S; Kesharwani D; Datta M
    J Cell Physiol; 2017 Nov; 232(11):2938-2945. PubMed ID: 28112397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Regulations in Diabetic Nephropathy.
    Lu Z; Liu N; Wang F
    J Diabetes Res; 2017; 2017():7805058. PubMed ID: 28401169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between microRNAs and the epigenetic machinery: an intricate network.
    Iorio MV; Piovan C; Croce CM
    Biochim Biophys Acta; 2010; 1799(10-12):694-701. PubMed ID: 20493980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting epigenetic regulators for treating diabetic nephropathy.
    Kushwaha K; Garg SS; Gupta J
    Biochimie; 2022 Nov; 202():146-158. PubMed ID: 35985560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of microRNAs in epigenetic regulation.
    Yao Q; Chen Y; Zhou X
    Curr Opin Chem Biol; 2019 Aug; 51():11-17. PubMed ID: 30825741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
    Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
    Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics and microRNAs.
    Chuang JC; Jones PA
    Pediatr Res; 2007 May; 61(5 Pt 2):24R-29R. PubMed ID: 17413852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs and epigenetics.
    Sato F; Tsuchiya S; Meltzer SJ; Shimizu K
    FEBS J; 2011 May; 278(10):1598-609. PubMed ID: 21395977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S; Bhattacharjee N
    Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease.
    Shelke V; Kale A; Sankrityayan H; Anders HJ; Gaikwad AB
    Arch Physiol Biochem; 2024 Apr; 130(2):230-241. PubMed ID: 34986074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA epigenetic signatures in human disease.
    Piletič K; Kunej T
    Arch Toxicol; 2016 Oct; 90(10):2405-19. PubMed ID: 27557899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics and miRNAs in human cancer.
    Fabbri M; Calin GA
    Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.
    Yuan H; Reddy MA; Deshpande S; Jia Y; Park JT; Lanting LL; Jin W; Kato M; Xu ZG; Das S; Natarajan R
    Antioxid Redox Signal; 2016 Mar; 24(7):361-75. PubMed ID: 26492974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs.
    Huang D; Cui L; Ahmed S; Zainab F; Wu Q; Wang X; Yuan Z
    Food Chem Toxicol; 2019 Jan; 123():574-594. PubMed ID: 30408543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
    Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
    J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifications in the pathogenesis of diabetic nephropathy.
    Reddy MA; Tak Park J; Natarajan R
    Semin Nephrol; 2013 Jul; 33(4):341-53. PubMed ID: 24011576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs and Epigenetics.
    Moutinho C; Esteller M
    Adv Cancer Res; 2017; 135():189-220. PubMed ID: 28882223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of microRNAs by epigenetics and their interplay involved in cancer.
    Liu X; Chen X; Yu X; Tao Y; Bode AM; Dong Z; Cao Y
    J Exp Clin Cancer Res; 2013 Nov; 32(1):96. PubMed ID: 24261995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.